Evidence map›Paper›PMID 18197815›Full record

ReviewCritical reviews in immunology2007

Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.

Zhenming Xu, Egest J Pone, Ahmed Al-Qahtani, Seok-Rae Park, Hong Zan, Paolo Casali

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. SUMO-specific protease 1 regulates germinal center B cell response through deSUMOylation of PAX5.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy.International journal of radiation oncology, biology, physics · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Role of Polycomb Complexes in Normal and Malignant Plasma Cells.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus.Frontiers in cellular and infection microbiology · 2020
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhenming XuCenter for Immunology, School of Medicine and School of Biological Sciences, University of California, Irvine, CA 92697-4120, USA.
Egest J Pone
Ahmed Al-Qahtani
Seok-Rae Park
Hong Zan
Paolo Casali
University of California, Irvine · USThe University of Texas Health Science Center at San Antonio · US

Funding

Somatic hypermutation and class switching in autoimmunityR01AI079705 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2010 to 2019
$4.1M
Immunoglobulin class switch DNA recombinationR01AI045011 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 2000 to 2011
$3.8M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
SOMATIC HYPERMUTATION IN HUMAN B CELLSR01AR040908 · NIAMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 1992 to 2005
$1.8M
Immunoglobulin class switch DNA recombinationR56AI045011 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2012 to 2012
$523k
Molecular mechanisms in the generation of autoantibodies and lupusR56AI079705 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2008 to 2008
$381k
NIAID NIH HHS AI 45011NIAID NIH HHS AI 60573NIAID NIH HHS R01 AI045011NIAID NIH HHS R01 AI079705NIAID NIH HHS R56 AI045011NIAID NIH HHS R56 AI079705NIAID NIH HHS T32 AI060573NIAMS NIH HHS AR 40908NIAMS NIH HHS R01 AR040908
6 · The paper itself

Abstract

Expression and activity of activation-induced cytidine deaminase (AID) encoded by the aicda gene are essential for immunoglobulin (Ig) gene somatic hypermutation (SHM) and class switch DNA recombination (CSR). SHM and CSR unfold, in general, in germinal centers and/are central to the maturation of effective antibody responses. AID expression is induced by activated B-cell CD40 signaling, which is critical for the germinal center reaction, and is further enhanced by other stimuli, including interleukin-4 (IL-4) secreted from CD4+ T cells or Toll-like receptor (TLR)-activating bacterial and/or viral molecules. Integration of different intracellular signal transduction pathways, as activated by these stimuli, leads to a dynamic aicda-regulating program, which involves both positively acting trans-factors, such as Pax5, HoxC4, E47, and Irf8, and negative modulators, such as Blimp1 and Id2, to restrict aicda expression primarily to germinal center B cells. The phosphatidylinositol 3-kinase (PI 3-K), which functions downstream of activated B-cell receptor (BCR) signaling, likely plays an important role in triggering the downregulation of aicda expression in postgerminal center B cells and throughout plasmacytoid differentiation. In B cells undergoing SHM and CSR, AID activity, and, possibly, AID targeting to the Ig locus are regulated at a posttranslational level, including AID dimerization/oligomerization, nuclear/cytoplasmic AID translocation, and phosphorylation of the AID Ser38 residue by protein kinase A (PKA). Here, we discuss the role of B-cell activation signals, transcription regulation programs, and posttranslational modifications in controlling aicda expression and AID activity, thereby delineating an integrated model of modulation of SHM and CSR in the germinal center reaction.

Indexed as

Gene Expression Regulation, EnzymologicImmunoglobulin Class SwitchingRecombination, GeneticSomatic Hypermutation, ImmunoglobulinAICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCell DifferentiationCytidine DeaminaseGerminal CenterHumansHyper-IgM Immunodeficiency SyndromeLymphocyte ActivationPhosphorylationReceptors, ImmunologicSignal TransductionAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseReceptors, ImmunologicTranscription Factors

Identifiers

PMID18197815
PMCPMC2994649
OpenAlexW2088354196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.